A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes. 1974

K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010259 Paranoid Disorders Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state. Paranoia,Paranoid Psychoses,Psychoses, Paranoid,Disorder, Paranoid,Disorders, Paranoid,Paranoias,Paranoid Disorder
D010868 Pimozide A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) Antalon,Orap,Orap forte,R-6238,R6238
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical

Related Publications

K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
January 1974, Acta psychiatrica Scandinavica. Supplementum,
K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
September 1974, Current therapeutic research, clinical and experimental,
K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
July 1977, Psychopharmacology bulletin,
K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
July 1977, Psychopharmacology bulletin,
K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
January 1974, Acta psychiatrica Scandinavica. Supplementum,
K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
March 1975, Diseases of the nervous system,
K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
January 1971, The Journal of clinical pharmacology and new drugs,
K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
July 1974, Current therapeutic research, clinical and experimental,
K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
July 1971, La Clinica terapeutica,
K Andersen, and G d'Elia, and B Hållberg, and C Perris, and W Rapp, and G Román
August 1976, Acta psychiatrica Scandinavica,
Copied contents to your clipboard!